A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: A randomised controlled trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 117, Issue 1, 2010, Pages 53-61

  Oppegaard, K S ^a   Lieng, M ^b   Berg, A ^b   Istre, O ^b   Qvigstad, E ^b   Nesheim, B I ^a  

^a Klinikk Hammerfest ^*  (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cervical ripening; Estradiol; Hysteroscopy; Misoprostol; Postmenopausal; Sequential trial

Indexed keywords

ESTRADIOL; MISOPROSTOL; PARACETAMOL; PLACEBO;

ADD ON THERAPY; ADULT; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; HYSTEROSCOPY; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; NORWAY; OUTCOME ASSESSMENT; PAIN; POSTMENOPAUSE; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNIVERSITY HOSPITAL; UTERINE CERVIX DILATATION; UTERINE CERVIX RIPENING; VAGINA BLEEDING; VAGINA DISCHARGE;

EID: 72149109336     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2009.02435.x     Document Type: Article

References (50)

1. Liggins GC. Cervical ripening as an inflammatory reaction. In : Ellwood DA, Anderson ABM, editors. Cervical Ripening as an Inflammatory Reaction: Clinical and Biochemical Investigation. Edinburgh : Churchill Livingstone, 1981, 1 9.
2. Stjernholm-Vladic Y, Stygar D, Mansson C, Masironi B, Akerberg S, Wang H, et al. Factors involved in the inflammatory events of cervical ripening in humans. Reprod Biol Endocrinol 2004 2 : 74.
3. Fiala C, Gemzell-Danielsson K, Tang OS, von Hertzen H. Cervical priming with misprostol prior to transcervical procedures. Int J Gynaecol Obstet 2007 99 (Suppl. 2 S168 71.
4. Kelly AJ, Alfirevic Z, Dowswell T. Outpatient versus inpatient induction of labour for improving birth outcomes. Cochrane Database Syst Rev 2009 15 : CD007372.
5. Grimes DA, Schulz KF, Cates WJ Jr. Prevention of uterine perforation during curettage abortion. J Am Med Assoc 1984 251 : 2108 2111.
6. Schulz KF, Grimes DA, Cates W Measures to prevent cervical injury during suction curettage abortion. Lancet 1983 i : 1182 1184.
7. Lichtenberg ES. Complications of osmotic dilators. Obstet Gynecol Survey 2004 59 : 528 536.
8. Prager M, Eneroth-Grimfors E, Edlund M, Marions L. A randomised controlled trial of intravaginal dinoprostone, intravaginal misoprostol and transcervical balloon catheter for labour induction. BJOG 2008 115 : 1443 1450.
9. Blanchard K, Clark S, Winikoff B, Gaines G, Kabani G, Shannon C. Misoprostol for Women's Health. Obstet Gynecol 2002 99 : 316 332.
10. Ashok PW, Flett GM, Templeton A. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. Am J Obstet Gynecol 2000 183 : 998 1002.
11. Thompson AJ, Lunan CB, Cameron AD, Cameron IT, Greer IA, Norman JE. Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial. Br J Obstet Gynaecol 1997 104 : 1054 1057.
12. Witter FR. Prostaglandin E2 preparations for preinduction cervical ripening. Clin Obstet Gynecol 2000 43 : 510 520.
13. Robert A, Nezamis JE, Philips JP. Inhibition of gastric secretion by prostaglandins. Am J Dig Dis 1967 12 : 1073 1076.
14. Weeks A, Faundes A. Misoprostol in obstetrics and gynecology. Int J Gynaecol Obstet 2007 99 (Suppl. 2 S156 9.
15. Ngai SW, Chan YM, Ho PC. The use of misoprostol prior to hysteroscopy in postmenopausal women. Hum Reprod 2001 16 : 1486 1488.
16. Loffer FD. Complications of hysteroscopy - their cause, prevention, and correction. J Am Assoc Gynecol Laparosc 1995 3 : 11 26.
17. Vilos GA, Vilos EC, King JH. Experience with 800 hysteroscopic endometrial ablations. J Am Assoc Gynecol Laparosc 1996 4 : 33 8.
18. Bradley LD. Complications in hysteroscopy: prevention, treatment and legal risk. Curr Opin Obstet Gynecol 2002 14 : 409 415.
19. Lieng M, Qvigstad E, Sandvik L, Jørgensen H, Langebrekke A, Istre O. Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps. J Minim Invasive Gynecol 2007 14 : 189 194.
20. Isaacson K. Complications of hysteroscopy. Obstet Gynecol Clin North Am 1999 26 : 39 51.
21. Rath W, Kuhn W, Hilgers R. Facilitation of cervical dilatation by intracervical application of sulprostone gel prior to hysteroscopy. Endoscopy 1985 17 : 191 193. (Pubitemid 15238169)
22. Crane JM, Healy S. Use of misoprostol before hysteroscopy: a systematic review. J Obstet Gynaecol Can 2006 28 : 373 379.
23. Oppegaard KS, Nesheim BI, Istre O, Qvigstad E. Comparison of self-administered vaginal misoprostol for cervical ripening prior to operative hysteroscopy using a sequential trial design. BJOG 2008 115 : 663. e1-9.
24. Oppegaard KS, Lieng M, Berg A, Istre O, Qvigstad E, Nesheim B-I. Does self-administered vaginal misoprostol result in cervical ripening in postmenopausal women after 14 days of pre-treatment with estradiol? Trial protocol for a randomized, placebo-controlled sequential trial. BJOG 2008 115 : 917. e10.
25. Skovlund E, Walløe L. A sequential two-sample test developed by stochastic simulation. J Statist Comput Simul 1988 29 : 87 104.
26. Skovlund E. Truncation of a two sample sequential Wilcoxon test. Biom J 1991 33 : 271 279.
27. Skovlund E, Walløe L. Sequential or fixed sample trial design? A case study by stochastic simulation. J Clin Epidemiol 1991 44 : 265 272.
28. Skovlund E, Fyllingen G, Landre H, Nesheim B-I. Comparison of postpartum pain treatments using a sequential trial design: I. Paracetamol versus placebo. Eur J Clin Pharmacol 1991 40 : 343 347.
29. Skovlund E, Fyllingen G, Landre H, Nesheim B-I. Comparison of postpartum pain treatments using a sequential trial design: II. Naproxen versus paracetamol. Eur J Clin Pharmacol 1991 40 : 539 542.
30. Skovlund E, Walløe L. Estimation of treatment difference following a sequential clinical trial. J Am Stat Assoc 1989 84 : 823 828.
31. CONSORT Group. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001 357 : 1191 1194.
32. Fung TM, Lam MH, Wong SF, Ho LC. A randomised placebo-controlled trial of vaginal misoprostol for cervical priming before hysteroscopy in postmenopausal women. BJOG 2002 109 : 561 565.
33. Bunnasathiansri S, Herabutya Y, O-Prasertsawat P. Vaginal misoprostol for cervical priming before dilatation and curettage in postmenopausal women: a randomized controlled trial. J Obstet Gynaecol 2004 30 : 221 225.
34. Barcaite E, Bartusevicius A, Railate DR, Nadisauskiene R. Vaginal misoprostol for cervical priming before hysteroscopy in perimenopausal and postmenopausal women. Int J Gynaecol Obstet 2005 91 : 141 145.
35. Thomas JA, Leyland N, Durand N, Windrim RC. The use of oral misoprostol as a cervical ripening agent in operative hysteroscopy: a double-blind, placebo controlled trial. Am J Obstet Gynecol 2002 186 : 876 879.
36. Atmaca R, Kafkasli A, Burak F, Tezcan TG. Priming effect of misoprostol on estrogen pretreated cervix in postmenopausal women. Tohoku J Exp Med 2005 206 : 237 241.
37. Yoshida K, Tahara R, Nakayama T, Yanaihara T. Effect of dehydroepiandrosterone sulphate, oestrogens and prostglandins on collagen metabolism in human cervical tissue in relation to cervical ripening. J Int Med Res 1993 21 : 26 35.
38. Taylor NF. Review: placental sulphatase deficiency. J Inherit Metab Dis 1982 5 : 164 176.
39. Mesiano S. Roles of estrogen and progesterone in human parturition. Front Horm Res 2001 27 : 86 104.
40. Arias F. Pharmacology of oxytocin and prostaglandins. Clin Obstet Gynecol 2000 43 : 455 468.
41. Strauss JF III., Martinez F, Kiriakidou M. Placental steroid hormone synthesis: unique features and unanswered questions. Biol Reprod 1996 54 : 303 311.
42. Rajabi MR, Dodge GR, Solomon S, Poole R. Immunochemical and immunohistological evidence of estrogen-mediated collagenolysis as a mechanism of cervical dilatation in the guinea pig at parturition. Endocrinology 1991 128 : 371 378.
43. Stygar D, Wang H, Vladic YS, Ekman G, Eriksson H, Sahlin L. Co-localization of oestrogen receptor [β] and leukocyte markers in the human cervix. Mol Hum Reprod 2001 7 : 881 886.
44. Ramos JG, Varayoud J, Kass L, Rodriguez H, Muñoz de Toro M, Montes GS, et al. Estrogen and progesterone modulation of eosinophilic infiltration of the rat uterine cervix. Steroids 2000 65 : 409 414.
45. Tromans PM. A comparative study of oestradiol and prostaglandin E2 vaginal gel for ripening the unfavourable cervix before induction of labour. Br Med J 1981 282 : 679.
46. Stjernholm Y, Sahlin L, Akerberg S, Elinder A, Eriksson HA, Ekman G. Cervical ripening in humans. Potential roles of estrogen, progesterone and insulin-like growth factor-I. Am J Obstet Gynecol 1996 174 : 1065 1071.
47. Thomas J, Kelly AJ, Kavavagh J. Oestrogens alone or with aminotomy for cervical ripening or induction of labour. Cochrane Database Syst Rev 2001 4 : 1 77.
48. Oppegaard KS, Abdelnoor M, Nesheim BI, Jerve F, Eskild A. The use of oral misoprostol for pre-abortion cervical priming: a randomised controlled trial of 400 mg versus 200 mg in first trimester pregnancies. BJOG 2004 111 : 154 159.
49. Oppegaard KS, Qvigstad E, Nesheim BI. Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial. BJOG 2006 113 : 58 64.
50. Cooper KG, Pinion SB, Bhattacharya S, Parkin DE. The effects of the gonadotrophin releasing hormone analogue (goserelin) and prostaglandin E1 (misoprostol) on cervical resistance prior to transcervical resection of the endometrium. Br J Obstet Gynaecol 1996 103 : 375 378.